首页> 外文期刊>Clinical Psychopharmacology and Neuroscience >Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report
【24h】

Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report

机译:阿立哌唑诱导的13岁女孩迟发性运动障碍成功用Biperiden治疗:一例报告

获取原文
       

摘要

In the last years second-generation antipsychotics are increasingly prescribed in the pediatric population for the treatment of several psychiatric disorders. Among the long term adverse effects, extrapyramidal symptoms (EPS) are less reported compared to first-generation antipsychotics. Tardive dyskinesia (TD) is a iatrogenic rare syndrome characterized by persistent slow writhing and sudden involuntary movements mainly involving the oral-buccal-lingual area with masticatory movements. We report a young girl with mood disorders accompanied by mild intellectual disability and behavioral problems who had TD after treatment with Aripiprazole, which responded to Biperiden therapy.
机译:在最近几年中,第二代抗精神病药在儿科人群中越来越多地用于治疗多种精神病。与第一代抗精神病药相比,在长期不良反应中,锥体外系症状(EPS)报道较少。迟发性运动障碍(TD)是一种医源性罕见综合征,其特征是持续缓慢扭动和突然的非自愿运动,主要累及口腔颊舌区域和咀嚼运动。我们报道了一个年轻的女孩,伴有轻度的智力障碍和行为问题,伴有轻度的智力障碍,使用阿立哌唑治疗后对TD有反应,对Biperiden治疗有反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号